There are better treatments for psoriatic arthritis (PsA) today than ever, but not everyone has the same access to them or gets equal care. That’s because of disparities, or preventable differences, ...

Many options are available to treat psoriatic arthritis (PsA), ranging from over-the-counter medicines to highly specialized therapies. Regardless of which is chosen, the overall goal is clear: ...

A GRAPPA working group highlighted the importance of screening for comorbidities to guide treatment selection among patients with psoriatic arthritis. Identifying important comorbidities and their ...

In December 2021, the US Food and Drug Administration (FDA) approved upadacitinib (Rinvoq ® [AbbVie, Inc.]), a Janus kinase (JAK) inhibitor, for the treatment of adults with active psoriatic arthritis ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So talking about treatment options in a ...

Moderate to severe psoriatic arthritis (PsA) correlates with worse mental health and higher financial burden, impacting quality of life and health care utilization. Black participants reported higher ...

Medically reviewed by Anita C. Chandrasekaran, MD Key Takeaways Psoriatic arthritis (PsA) progresses through four stages: ...

This article was originally published by Dermatology Times®. It has been lightly edited. Researchers found that treatment of psoriatic arthritis (PsA) varied depending on clinical specialization in ...